MALARIA 

Malaria is caused by Plasmodium parasites. The parasites are transmitted to people through the bite of infected female Anopheles mosquitoes. There are five disease-causing Plasmodium species, but P. falciparum is the predominant parasite worldwide, with exception of the Americas where P. vivax accounts for the majority of Malaria cases.

Malaria is an acute febrile illness. Frequent symptoms include fever, chills and headache, if left untreated it can progress to severe manifestations, such as severe anaemia and cerebral malaria. 

Due to global efforts malaria deaths have been reduced by half, since 2010. Still...

Every 2 minutes, a child dies of malaria.

Malaria is curable and preventable. Methods of prevention include vector control, insecticide-treated nets and Intermittent preventive treatment in pregnant women and infancy.

67%

of all deaths occur in children under 5

228 Mio

cases annually

  93%  

of all cases occur in Africa

≈ 44%

of the world's population at risk

at a glance

World Malaria Day is celebrated on 25th April, as an opportunity to raise awareness and mobilise political commitment 

towards Malaria research, control and prevention.

Vaccines, the way forward

Currently there are no licensed Malaria vaccines available. EVI's recent efforts to develop malaria vaccines by building a portfolio that encompasses blood-stage malaria vaccines, including targeting placental malaria, and as well as pre-erythrocytic and combination malaria vaccines. 

Vaccine candidates

Discovery

Pre-clinical proof of concept

Clinical proof of concept

    Phase Ia    

    Phase Ib    

    Phase IIa    

Development

      Phase IIb     

    Phase III   

Multi-stage vaccine

Blood-stage 

Join European Vaccine Initiative mailing list for updates on projects, training and funding opportunities

© 2020 European Vaccine Initiative. Designed by European Vaccine Initiative